港股上市公司荣昌生物（09995.HK）今日盘中大跌5.01%，引发市场关注。分析人士认为，这一走势可能与即将公布的第一季度业绩报告以及近期的股价强势上涨有关。
据悉，荣昌生物将于4月28日发布2025年第一季度业绩报告。在业绩公布前夕，部分投资者选择获利了结，导致股价出现回调。值得注意的是，荣昌生物近期股价表现强劲，过去20个交易日累计上涨85.84%，如此快速的涨幅也增加了短期回调的可能性。
此外，南向资金动向也可能影响了股价走势。数据显示，4月16日南向资金减持荣昌生物176.60万股，这反映出部分内地投资者对该股近期表现持谨慎态度。尽管如此，截至4月16日收盘，港股通仍持有荣昌生物7239.05万股，占流通股的38.18%，显示机构投资者对公司长期发展仍保持信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.